• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Pharma’s grip on cancer R&D is having unintended consequences

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 13, 2024 at 11:02: AM
via Pharma industry sponsors are dominating clinical cancer research at a level that’s increased “dramatically” from decades past, according to a study published in The Journal of Clinical Oncology.

article source
 




Top Bottom
Back
Quote